Back to search

Pharmidex Pharmaceutical Services Limited

04441512

active
Private Limited Company
england wales
Companies House
Health Score
88 / 100

Healthy

30/30
Filing
20/30
Financial
38/40
Risk
  • 1 outstanding charge (-2)

Details

167-169 GREAT PORTLAND STREET, LONDON, W1W 5PF
Incorporated 17/05/2002

Compliance

Last accounts

30/06/2025

total exemption full

Next accounts due

31/03/2027

On track

Confirmation statement

Last: 17/05/2025

Due 31/05/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Professor Mohammad Sadeghi-Alavijeh

secretary · Since 17/05/2002

BRITISH · ENGLAND · Age 64

Also on 5 other boards

Professor Mohammad Sadeghi-Alavijeh

director · Since 17/05/2002

CO FOUNDER AND MANAGING DIRECT

BRITISH · ENGLAND · Age 64

Also on 5 other boards

A2e Capital Partners Limited

director · Since 11/03/2011

BRITISH

Also on 40 other boards

Persons with Significant Control

Pharmidex Holdings Ltd

75–100% shares

167-169, Great Portland Street, London, W1W 5PF

Reg: 07881789 · Companies House · Limited Company

Notified 06/04/2016

Charges1 outstanding

Charge
outstanding

FLEXICARE (GROUP) LIMITED

Created 07/03/2019Registered 11/03/2019
charge
satisfied

E2E VENTURE CATALYSTS LIMITED (THE CREDITOR)

Created 31/12/2011Registered 06/01/2012Satisfied 12/03/2019
charge
satisfied

FLEXICARE MEDICAL LIMITED (THE CREDITOR)

Created 31/12/2011Registered 06/01/2012Satisfied 12/03/2019
charge
satisfied

MOHAMMED ALAVIJEH

Created 31/12/2011Registered 06/01/2012Satisfied 12/03/2019
charge
satisfied

A2E VENTURE CATALYSTS LIMITED

Created 19/01/2011Registered 25/01/2011Satisfied 11/03/2019
charge
satisfied

MOHAMMED ALAVIJEH

Created 19/01/2011Registered 25/01/2011Satisfied 11/03/2019
charge
satisfied

FLEXICARE MEDICAL LIMITED

Created 19/01/2011Registered 25/01/2011Satisfied 11/03/2019
charge
satisfied

THE GOVERNOR AND COMPANY OF THE BANK OF SCOTLAND

Created 10/11/2003Registered 11/11/2003Satisfied 29/09/2020

CompanyRankvs 144+ SIC 72110 peers
71

Financial strength95th percentile among SIC peers · 24/25
Employees98th percentile among SIC peers · 15/15
LiquidityCurrent ratio 1.07× · 12/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity12/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/06/2025

Net Worth

£2.2M

Balance sheet strength

Cash

£436k

Cash in the bank

Net Current Assets

£123k

Working capital

Current Assets

£1.9M

Current Liabilities

£1.8M

Fixed Assets

£2.6M

Debtors

£790k

33avg. employees-2

Balance Sheet

Intangible assets£446k
Assets less current liabilities£2.7M
Signed by Professor Mohammad Alavijeh 12 August 2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20251.07+£170k
20241.20+£1.1M
20240.74-£160k
20230.80+£232k
20231.02+£29k
20221.18+£10k
20221.19+£42k
20211.28+£34k
20211.19+£155k
20201.18

Derived from filed accounts. Not audited figures.